Cryosite Limited (ASX:CTE)

Market Cap	48.81M +65.3%
Revenue (ttm)	15.75M +22.6%
Net Income	2.18M +19.2%
EPS	0.04 +14.4%
Shares Out	48.81M
PE Ratio	23.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	900
Average Volume	6,476
Open	1.070
Previous Close	1.000
Day's Range	1.000 - 1.070
52-Week Range	0.660 - 1.300
Beta	0.21
RSI	32.97
Earnings Date	May 27, 2026

About Cryosite

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and r...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 25
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CTE

Financial Performance

In fiscal year 2025, Cryosite's revenue was 14.12 million, an increase of 11.93% compared to the previous year's 12.61 million. Earnings were 1.88 million, an increase of 2.39%.